Home
>
National Drug Code (NDC)
>
Pantoprazole Sodium
Pantoprazole Sodium - 0008-0606-01 - (PANTOPRAZOLE SODIUM)
Drug Information of Pantoprazole Sodium
| Product NDC: | 0008-0606 |
| Proprietary Name: | Pantoprazole Sodium |
| Non Proprietary Name: | PANTOPRAZOLE SODIUM |
| Active Ingredient(s): | 20 mg/1 & nbsp; PANTOPRAZOLE SODIUM |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, DELAYED RELEASE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Pantoprazole Sodium
| Product NDC: | 0008-0606 |
| Labeler Name: | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA020987 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20080131 |
Package Information of Pantoprazole Sodium
| Package NDC: | 0008-0606-01 |
| Package Description: | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (0008-0606-01) |
NDC Information of Pantoprazole Sodium
| NDC Code | 0008-0606-01 |
| Proprietary Name | Pantoprazole Sodium |
| Package Description | 90 TABLET, DELAYED RELEASE in 1 BOTTLE (0008-0606-01) |
| Product NDC | 0008-0606 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | PANTOPRAZOLE SODIUM |
| Dosage Form Name | TABLET, DELAYED RELEASE |
| Route Name | ORAL |
| Start Marketing Date | 20080131 |
| Marketing Category Name | NDA |
| Labeler Name | Wyeth Pharmaceuticals Company, a subsidiary of Pfizer Inc. |
| Substance Name | PANTOPRAZOLE SODIUM |
| Strength Number | 20 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Proton Pump Inhibitor [EPC],Proton Pump Inhibitors [MoA] |
